Supporting UK Innovation in Regenerative Medicine through Standardization
26th February 2008
The development of a vibrant regenerative medicine industry is potentially of enormous benefit to the UK economy and quality of life. There are, however, likely to be significant barriers to successful commercialization of regenerative medicine products. Some of these will be overcome through the timely introduction of appropriate standards.
Attend this free, invitation-only BSI British Standards event:
- To have your say in shaping the direction the UK should take in regard to future standardization in regenerative medicine;
- To be aware of the latest developments in the UK Technology Strategy in regenerative medicine; and;
- For the latest updates on developments in Directives, Regulations and Standards from the UK, Europe and international arenas
This is an opportunity to ensure that BSI’s future standards work supports you in your business, and accurately represents your interests beyond the UK.
As well as discussions, you will have the opportunity to network with your peers and hear from key industry experts on:
- UK Technology Strategy in regenerative medicine
- Regulation update
- Update on Standards (UK, European and International)
- The future of regenerative medicine
- Case study: successful commercialization of regenerative medicine
Chair:
Prof David Williams, Professor of Healthcare Engineering, Head of Remedi Consortium, University of Loughborough
Key speakers include
Dr Christopher Bravery, Pharmaceutical Assessor, Biologicals and Biotechnology Unit, MHRA
Dr Merlin Goldman, Lead technologist - Bioscience and Healthcare, Technology Strategy Board
Dr Penny Johnson, Director of Research, UK, Intercytex
Dr Chris Mason, Stem Cell and Regenerative Medicine Bioprocessing Unit, University College London
Dr Ben Sheridan, Committee Manager, BSI British Standards
Dr Paul Tomlins, Project Leader, National Physical Laboratory
Who should attend
All senior managers and directors of organizations with interest in regenerative medicine and related technologies, including those working in:
Business development, Quality assurance and Risk
This event is free of charge by invitation only. Places are limited and you must RSVP to secure your place.
Venue
London